U.S., Sept. 3 -- As first emergency use authorisations for COVID-19 vaccines are expected to be effective during the final quarter of 2020, logistics providers are anticipated to increasingly establish medical supply chains to deliver serums of unparalleled amounts of over 10 billion doses globally.
There are currently over 250 vaccines across seven platforms being developed and trialled. As COVID-19 vaccines have leapfrogged development phases, stringent temperature requirements of up to -80Degree C are expected to be imposed for certain vaccines to make sure their efficacy is maintained during transportation and warehousing. This will mean novel logistics challenges to the existing medical supply chain that conventionally distributes va...